Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis
Protocol ID
LCH-IV
Disease (Sub Disease)
Langerhans Cell Histiocytosis
Diagnosis Stage
New diagnosis
Location
NSW, QLD, VIC, WA, NZ
Sponsor
North American Consortium for Histiocytosis
Collaborators
Histiocyte Society
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 18 years
International registry ID's
NCT02205762
Back to Registry
Study Title International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis
Protocol ID LCH-IV
Disease (Sub Disease) Langerhans Cell Histiocytosis
Diagnosis Stage New diagnosis
Location NSW / QLD / VIC / WA / NZ
Sponsor North American Consortium for Histiocytosis
Collaborators Histiocyte Society
Links https://clinicaltrials.gov/ct2/show/NCT02205762
Trial Status Open
Trial Open Date 14/04/2014
Sites The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Christchurch Hospital / Starship Hospital
Study Type Treatment
Phase Phase 3
Age Eligibility up to 18 years
International registry ID's NCT02205762